Athens Medical C.S.A. (AT:IATR) — Stock Price
Athens Medical C.S.A. (AT:IATR) is currently trading at €1.65 EUR, up 0.61% today. Over the past 52 weeks, shares have ranged between €1.54 and €2.30. This page tracks Athens Medical C.S.A.'s live share price on the AT exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Athens Medical C.S.A. stock valuation.
Athens Medical C.S.A. (IATR) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Athens Medical C.S.A.'s daily closing share price and trading volume on the AT exchange over the past year, giving a clear view of recent price momentum and liquidity.
Athens Medical C.S.A. Income Statement — Revenue, Profit & Earnings by Year
Athens Medical C.S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €269.85 Million | €258.36 Million | €233.42 Million | €226.00 Million | €187.50 Million |
| Cost of Revenue | €209.08 Million | €191.81 Million | €176.61 Million | €168.21 Million | €147.01 Million |
| Gross Profit | €60.76 Million | €66.56 Million | €56.81 Million | €57.79 Million | €40.49 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €7.51 Million | €5.38 Million | €34.62 Million | €31.63 Million | €28.84 Million |
| Total Operating Expenses | €258.04 Million | €237.61 Million | €213.23 Million | €201.73 Million | €186.19 Million |
| Operating Income | €11.81 Million | €20.75 Million | €18.41 Million | €21.37 Million | €7.89 Million |
| EBITDA | — | — | €32.13 Million | €34.78 Million | €23.98 Million |
| EBIT | — | — | €18.41 Million | €21.37 Million | €7.80 Million |
| Interest Expense | €10.70 Million | €9.33 Million | €7.63 Million | €6.55 Million | €6.14 Million |
| Income Before Tax | €4.49 Million | €13.70 Million | €10.71 Million | €15.34 Million | €3.62 Million |
| Income Tax Expense | — | — | €3.80 Million | €3.30 Million | €1.19 Million |
| Net Income | €1.78 Million | €8.08 Million | €6.85 Million | €15.05 Million | €3.92 Million |
Athens Medical C.S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Athens Medical C.S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €495.86 Million | €477.34 Million | €418.09 Million | €422.76 Million | €418.54 Million |
| Total Current Assets | €191.87 Million | €197.00 Million | €159.81 Million | €163.45 Million | €161.37 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | €16.35 Million | €51.60 Million | €48.96 Million |
| Net Receivables | €122.43 Million | €130.14 Million | €97.76 Million | €63.89 Million | €59.80 Million |
| Inventory | €7.21 Million | €6.94 Million | €7.00 Million | €7.00 Million | €6.89 Million |
| Property, Plant & Equipment | — | — | €254.66 Million | €249.69 Million | €249.27 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €387.05 Million | €368.57 Million | €314.84 Million | €320.69 Million | €331.48 Million |
| Total Current Liabilities | €230.76 Million | €200.29 Million | €145.50 Million | €135.32 Million | €231.23 Million |
| Long-term Debt | €69.76 Million | €89.74 Million | €110.58 Million | €116.72 Million | €26.06 Million |
| Net Debt | €108.88 Million | €118.40 Million | €111.68 Million | €81.45 Million | €86.17 Million |
| Total Stockholder Equity | €108.61 Million | €108.67 Million | €103.25 Million | €102.06 Million | €87.07 Million |
| Retained Earnings | €51.70 Million | €51.76 Million | €43.74 Million | €37.38 Million | €40.45 Million |
Athens Medical C.S.A. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Athens Medical C.S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €46.44 Million | €26.13 Million | €124.00K | €15.75 Million | €40.21 Million |
| Capital Expenditures | €26.63 Million | €22.35 Million | €15.87 Million | €11.28 Million | €7.08 Million |
| Free Cash Flow | €19.82 Million | €3.78 Million | €-15.75 Million | €4.46 Million | €33.13 Million |
| Investing Cash Flow | — | — | €-15.78 Million | €-6.95 Million | €-7.11 Million |
| Financing Cash Flow | — | — | €-19.64 Million | €-6.07 Million | €8.67 Million |
| Dividends Paid | €-1.73 Million | €-61.00K | — | €81.00K | €141.00K |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €16.80 Million | €14.93 Million | €13.78 Million | €12.89 Million | €11.69 Million |
| Change in Cash | €-4.45 Million | €5.28 Million | €-35.30 Million | €2.73 Million | €41.76 Million |
Athens Medical C.S.A. Earnings History — EPS Actual vs. Analyst Estimates
Track Athens Medical C.S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 05, 2025 | — | — | — |
| Dec 31, 2017 | -0.03 | — | — |
| Mar 31, 2016 | -0.08 | — | — |
| Nov 30, 2015 | -0.07 | — | — |
| Aug 31, 2015 | -0.07 | — | — |
| May 29, 2015 | 0.04 | — | — |
| Nov 28, 2014 | -0.06 | — | — |
| Aug 29, 2014 | 0.03 | — | — |